LOGEX offers a comprehensive software portfolio to support a holistic approach to healthcare improvement. The company’s advanced analytics tools transform data into actionable insight. This enables stakeholders in the healthcare system to transition towards more qualitycentric and costconscious healthcare through an unprecedented level of insight into performance, outcomes and costs.

LOGEX core geographical markets are the Netherlands, Sweden, Finland, Norway, Germany and the UK. LOGEX' solutions benefit the healthcare system as a whole, including payors, providers and patients.

Around 700 providers are using LOGEX platform and almost 40 million unique patients have been impacted by insights derived from the Group's analytic tools. LOGEX Group's solutions are supporting around €70bn in healthcare funding decisions annually, demonstrating the effect that LOGEX Group has on its stakeholders.

Without LOGEX solutions, healthcare providers would not have the same level of clarity on the relative performance of their operations and data-driven tools allowing them to effectively manage costs and quality of care. This could negatively impact the quality patients receive and thereby lead to suboptimal outcomes in terms of lower quality, higher costs or greater variability.

The slow pace of transformation of healthcare systems towards quality-centric care and value-based healthcare presents a potential risk for LOGEX. While there is evidence of a change starting to emerge, we are yet to reach the real inflection point for more rapid change. Another risk LOGEX faces is related to data security and privacy. The company has invested heavily to maintain the highest security standards and has obtained several internationally recognized certifications.